Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors
Conexeu Sciences closed an approximately $5 million private placement of 1,666,667 units at $3.00, each with one share and a two-year warrant exercisable at $3.00, led by existing shareholders, management and directors. $250,000 of management and director subscriptions sit in escrow pending stockholder approval under Nasdaq Listing Rule 5635(c); if approval fails, those funds are returned and the securities not issued. Proceeds fund working capital, manufacturing scale-up, regulatory testing and preclinical work supporting a planned FDA 510(k) submission for Ten Minute Tissue targeted for Q1 2027.
Key figures
- Deal Value Usd
- 5000000
- Offering Price
- 3
- Shares Offered
- 1666667
- Escrow condition
- Nasdaq Listing Rule 5635(c) stockholder approval
- Escrowed proceeds
- 250000
- Warrant term months
- 24
- Warrant exercise price
- 3
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.